These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6191128)

  • 1. Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle.
    Isaacs JT
    J Steroid Biochem; 1983 Jun; 18(6):749-57. PubMed ID: 6191128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
    Isaacs JT; Brendler CB; Walsh PC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):139-46. PubMed ID: 6183287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
    Isaacs JT; Coffey DS
    Endocrinology; 1981 Feb; 108(2):445-53. PubMed ID: 6161001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrotestosterone concentration of beagle prostatic tissue: effect of age and hyperplasia.
    Ewing LL; Berry SJ; Higginbottom EG
    Endocrinology; 1983 Dec; 113(6):2004-9. PubMed ID: 6196180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrotestosterone accumulation in genital skin fibroblasts derived from elderly men with prostatic hyperplasia.
    Morimoto I; Eto S; Inoue S; Izumi M; Hara T; Saito Y; Nagataki S
    J Clin Endocrinol Metab; 1992 Aug; 75(2):632-5. PubMed ID: 1379259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dihydrotestosterone in benign prostatic hyperplasia.
    Carson C; Rittmaster R
    Urology; 2003 Apr; 61(4 Suppl 1):2-7. PubMed ID: 12657354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
    Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
    J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen metabolism in the epithelial and stromal components of the human hyperplastic prostate.
    Habib FK; Tesdale AL; Chisholm GD; Busuttil A
    J Endocrinol; 1981 Oct; 91(1):23-32. PubMed ID: 6170712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
    Krieg M; Nass R; Tunn S
    J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid hormones and the pathogenesis of benign prostatic hyperplasia.
    Griffiths K; Eaton CL; Harper ME; Peeling B; Davies P
    Eur Urol; 1991; 20 Suppl 1():68-77. PubMed ID: 1722166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of androgen metabolites in benign prostatic hypertrophy (BPH) and normal prostate.
    Geller J; Albert J; Lopez D; Geller S; Niwayama G
    J Clin Endocrinol Metab; 1976 Sep; 43(3):686-8. PubMed ID: 60347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative aspects of prostatic growth and androgen metabolism with aging in the dog versus the rat.
    Berry SJ; Isaacs JT
    Endocrinology; 1984 Feb; 114(2):511-20. PubMed ID: 6581042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductive metabolism of 5 alpha-dihydrotestosterone by rat ventral and dorsolateral prostate: kinetic parameters of the enzymes.
    Lee KH; Ofner P
    J Steroid Biochem; 1988 May; 29(5):553-7. PubMed ID: 2837610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of androgens in human hyperplastic prostate: evidence for a differential localization of the enzymes involved in the metabolism.
    Abalain JH; Quemener E; Carre JL; Simon B; Amet Y; Mangin P; Floch HH
    J Steroid Biochem; 1989; 34(1-6):467-71. PubMed ID: 2483221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression.
    Cohen SM; Werrmann JG; Rasmusson GH; Tanaka WK; Malatesta PF; Prahalada S; Jacobs JG; Harris G; Nett TM
    Prostate; 1995 Feb; 26(2):55-71. PubMed ID: 7531846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
    Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
    J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
    Smith CM; Ballard SA; Wyllie MG; Masters JR
    J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):151-9. PubMed ID: 7519439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.